A detailed history of Frazier Financial Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 2,370 shares of NVO stock, worth $249,489. This represents 0.22% of its overall portfolio holdings.

Number of Shares
2,370
Previous 1,856 27.69%
Holding current value
$249,489
Previous $265 Million 6.52%
% of portfolio
0.22%
Previous 0.21%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$119.07 - $145.42 $61,201 - $74,745
514 Added 27.69%
2,370 $282 Million
Q2 2024

Aug 12, 2024

BUY
$122.71 - $146.91 $14,479 - $17,335
118 Added 6.79%
1,856 $265 Million
Q1 2024

May 13, 2024

BUY
$102.11 - $135.92 $21,953 - $29,222
215 Added 14.12%
1,738 $223 Million
Q4 2023

Feb 09, 2024

BUY
$87.78 - $105.45 $133,688 - $160,600
1,523 New
1,523 $158 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Frazier Financial Advisors, LLC Portfolio

Follow Frazier Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frazier Financial Advisors, LLC with notifications on news.